KUNTUO

Top

Kun Tuo
Established for 15 Years
Kun Tuo, a wholly owned subsidiary by the global medicine health leader IQVIA, was built up in China in 2011, dedicated to providing pharmaceutical and medical device companies which conduct clinical trials in China with clinical trial solutions at one-stop range from IND to NDA.
The Trusted Choice of CRO Service Your Reliable CRO Partner
IQVIA Local Clinical Development Solutions in China
The Trusted Choice of CRO Service Your Reliable CRO Partner
Kun Tuo
IQVIA Local Clinical Development Solutions in China
Kun Tuo, a wholly owned subsidiary by the global medicine health leader IQVIA, was built up in China in 2011, dedicated to providing pharmaceutical and medical device companies which conduct clinical trials in China with clinical trial solutions at one-stop range from IND to NDA.
Kun Tuo
Company Introduction
Provide Pharmaceutical, Medical Device and In Vitro Diagnostic Agent Companies with High-quality Clinical Study Services
To date, our company has provided services for more than 1400 clinical studies in leading pharmaceutical and device companies in China and abroad, with customized options to help Chinese and Global biological drug and device manufacturing companies register new products in China successfully.

15

years
Rooted in China for

>

1400

clinical trial projects
Experienced in

>

520

medical devices
Assisted on the approval of

>

20

new drugs market launch
Facilitated

100

%
first pass rate for OHGRA meeting review

100

%
pass rate for NMPA review

100

%
pass rate for FDA review
Kun Tuo News
Provide the Latest News of Kun Tuo and the Industry